---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-089576"
form_type: "8-K"
ticker: "BTSG"
cik: "0001865782"
company_name: "BrightSpring Health Services, Inc."
filed_at: "2024-08-02T23:59:59+00:00"
generated_at: "2026-05-31T13:30:38.096738+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# BrightSpring Q2 revenue up 26% to $2.73B, raises FY2024 guidance

## Summary
- Revenue $2.73B (+26% YoY); net income $19.4M vs $2.8M in Q2 2023.
- Adj. EBITDA $139M (-6.9% YoY) but excluding $30M 2023 QIP, up 16.7%.
- Pharmacy Solutions revenue $2.11B (+32%); Provider Services $616M (+8%).
- FY2024 guidance raised: revenue $10.45-10.9B, Adj. EBITDA $570-580M.
- CEO cites strong segment growth and operational execution.

## SEC filing metadata
- accession: 0000950170-24-089576
- form_type: 8-K
- ticker: BTSG
- cik: 0001865782
- company_name: BrightSpring Health Services, Inc.
- filed_at: 2024-08-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1865782/000095017024089576/0000950170-24-089576-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1865782/000095017024089576/btsg-20240802.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-089576
- JSON: https://secwatch.observer/filing/0000950170-24-089576.json
- Plain text: https://secwatch.observer/filing/0000950170-24-089576.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.